4.6 Article

Magnetic Resonance Elastography to Assess Fibrosis in Kidney Allografts

Journal

Publisher

AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.01830217

Keywords

-

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. National Sciences and Engineering Research Council of Canada
  3. Physicians' Services Incorporated Foundation
  4. Astellas Pharma Canada [SG-185]
  5. St. Michael's Hospital Foundation
  6. Kidney Research Scientist Core Education and National Training Program New Investigator
  7. Canadian Diabetes Association Clinician Scientist salary support award
  8. CIHR New Investigator Award

Ask authors/readers for more resources

Background and objectives Fibrosis is a major cause of kidney allograft injury. Currently, the only means of assessing allograft fibrosis is by biopsy, an invasive procedure that samples <1% of the kidney. We examined whether magnetic resonance elastography, an imaging-based measure of organ stiffness, could noninvasively estimate allograft fibrosis and predict progression of allograft dysfunction. Design, setting, participants, & measurements Kidney allograft recipients >1 year post-transplant undergoing an allograft biopsy first underwent free-breathing, flow-compensated magnetic resonance elastography on a 3.0-T magnetic resonance imaging scanner. Each patient had serial eGFR measurements after the elastography scan for a follow-up period of up to 1 year. The mean stiffness value of the kidney allograft was compared with both the histopathologic Banff fibrosis score and the rate of eGFR change during the follow-up period. Results Sixteen patients who underwent magnetic resonance elastography and biopsy were studied (mean age: 54 9 years old). Whole-kidney mean stiffness ranged between 3.5 and 7.3 kPa. Whole-kidney stiffness correlated with biopsy-derived Banff fibrosis score (Spearman rho =0.67; P<0.01). Stiffness was heterogeneously distributed within each kidney, providing a possible explanation for the lack of a stronger stiffness-fibrosis correlation. We also found negative correlations between whole-kidney stiffness and both baseline eGFR (Spearman rho = -0.65; P<0.01) and eGFR change over time (Spearman rho = -0.70; P<0.01). Irrespective of the baseline eGFR, increased kidney stiffness was associated with a greater eGFR decline (regression r(2)=0.48; P=0.03). Conclusions Given the limitations of allograft biopsy, our pilot study suggests the potential for magnetic resonance elastography as a novel noninvasive measure of whole-allograft fibrosis burden that may predict future changes in kidney function. Future studies exploring the utility and accuracy of magnetic resonance elastography are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available